Israel Begins Clinical Trials of COVID-19 Vaccine

November 4, 2020

Israel Begins Clinical Trials of COVID-19 Vaccine

Israel will begin testing its BriLife vaccine, which was developed at Israel Institute for Biological Research on healthy volunteers as soon as early November. “Our final goal is 15 million doses for the residents of the State of Israel and for our close neighbors,” said Prof. Shmuel Shapira, director of the IIBR. Yourway operates a local depot with 7,5000 sq ft of capacity in Tel Aviv, to easily service Israel and the Mid-East region.

Back to Index

Media

Upcoming Events

Clinical Trial Supply East Coast 2022

October 19-20, 2022
King of Prussia, PA, USA

Schedule a Meeting

Media

Articles

Helping Sponsors Navigate Complex Ancillary Supply Sourcing Challenges with Integrated Services

Open chat

Hello! How can I help you?